0001127602-21-023386.txt : 20210809
0001127602-21-023386.hdr.sgml : 20210809
20210809185449
ACCESSION NUMBER: 0001127602-21-023386
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210806
FILED AS OF DATE: 20210809
DATE AS OF CHANGE: 20210809
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Johnson Lloyd Emerson
CENTRAL INDEX KEY: 0001708823
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14041
FILM NUMBER: 211157875
MAIL ADDRESS:
STREET 1: 16737 NEW PROVIDENCE LANE
CITY: CHARLOTTE
STATE: NC
ZIP: 28277
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HAEMONETICS CORP
CENTRAL INDEX KEY: 0000313143
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 042882273
STATE OF INCORPORATION: MA
FISCAL YEAR END: 0402
BUSINESS ADDRESS:
STREET 1: 125 SUMMER STREET
CITY: BOSTON
STATE: MA
ZIP: 02110
BUSINESS PHONE: 7818487100
MAIL ADDRESS:
STREET 1: 125 SUMMER STREET
CITY: BOSTON
STATE: MA
ZIP: 02110
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2021-08-06
0000313143
HAEMONETICS CORP
HAE
0001708823
Johnson Lloyd Emerson
125 SUMMER STREET
BOSTON
MA
02110
1
Common Stock
2021-08-06
4
A
0
3077
A
3077
D
The securities awarded are in the form of restricted stock units ("RSUs") issued pursuant to the Haemonetics Corporation 2019 Long-Term Incentive Compensation Plan. The RSUs vest 100% on the first anniversary of the date of grant.
Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested.
/s/ Thomas V. Powers, attorney-in-fact for Mr. Johnson
2021-08-09